Fuzhou, Fujian, China
NCT Number: NCT07020130
Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI (PRECISE)
A prospective observational study included all patients undergoing percutaneous coronary intervention(PCI) in Fujian Provincial Hospital from January 1st 2012 to December 31st 2018. The aim was to determine the incidence,risk factors,prophylactic strategy and outcomes of CI-AKI in patients undergoing PCI.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Critically ill patients undergoing PCI at ICU
Exclusion criteria
- pregnancy lactation end-stage renal disease (eGFR <15 mL/min/1.73 m2) long-term dialysis treatment intravascular administration of contrast medium within the last 7 or 3 days postoperatively
Treatment and study plan
Primary outcomes
-
CI-AKI
Time frame: 5 year
This was due to acute kidney injury following the use of intravascular contrast media. Serum creatinine is the primary measuring modalities.
-
CKD
Time frame: 5 year
Chronic renal structural and functional disorders that occurred during follow-up after administration of intravascular contrast agents, estimated glomerular filtration rate (eGFR) as the primary measuring modalities.
Secondary outcomes
-
all-cause mortality
Time frame: 5 year
Defined as deaths occurring during follow-up after discharge from EPCI, excluding force majeure factors such as natural disasters and car accidents,and the necessary information was gathered during follow-up.
Sponsors and collaborators
Lead sponsor
Kaiyang Lin
Other
Registry information
Official study title
Risk Factors,PREvention and outComes for Contrast-Induced Acute Kidney Injury in patientS undErgoing Percutaneous Coronary Intervention:a Single-center Cohort Study(PRECISE)
Acronym: PRECISE
Important dates
- Study start
- 2012
- Primary completion
- 2018
- Study completion
- 2018
- First posted
- Jun 13, 2025
- Registry last updated
- Jun 13, 2025
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy
NCT04809727
CIN, Cancer of Cervix
Tanta, Gharbia Governorate, Egypt
View Trial DetailsCervical Cancer Early Endpoints and Determinants
NCT00339989
CIN, Cervical Cancer
Oklahoma City, Oklahoma, United States
View Trial DetailsStudy of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
NCT03239223
CIN, Cervical Cancer
Los Angeles, California, United States
View Trial DetailsRisk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)
NCT03791606
CIN
Fuzhou, Fujian, China
View Trial Details